Treatment of glucocorticoid induced hyperglycemia in patients with type 2 diabetes mellitus with omarigliptin at Okayama university hospital: an open label randomized controlled trial

Not Applicable

• Conditions: Type 2 diabetes mellitus

• Registration Number: JPRN-UMIN000026022
• Lead Sponsor: Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-04-19
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Not provided

Exclusion Criteria

1) Type 1 diabetes mellitus 2) Concomitant glucocorticoid pulse therapy 3) Treated with insulin or dipeptidyl peptidase-4 inhibitor 4) Malignancy 5) Pregnant or breastfeeding 6) Difficulty in taking pills 7) Autoimmune pancreatitis 8) Patients who are considered as inappropriate for attending this study by their physicians

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of patients who were treated with insulin or whose plasma glucose levels elevated above 200mg/d

Secondary Outcome Measures

Name	Time	Method
1) Insulin therapy 2) Other treatments of DM 3) Adverse events 4) HbA1c 5) Glycoalbumin 6) 1,5-AG